Lista de obras - Lars Dyrskjøt - Dominio Público Uruguay

A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine

artículo científico publicado en 2013

A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays

artículo científico publicado en 2007

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

artículo científico publicado en 2005

A dual program for translation regulation in cellular proliferation and differentiation

artículo científico publicado en 2014

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.

artículo científico publicado en 2012

APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer

scientific article published on 08 April 2019

Abstract 3657: MCM7, ADAM10, TRIM29, Aurora Kinase B, and Cyclin D1: A panel of prognostic protein markers for progression in non-muscle invasive bladder cancer - a multicenter tissue microarray validation study

Adaptive differences in gene expression in European flounder (Platichthys flesus)

article

Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis

artículo científico publicado en 2008

Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway

artículo científico publicado en 2010

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

artículo científico publicado en 2021

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

artículo científico publicado en 2019

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.

artículo científico publicado en 2012

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

scientific article published on 02 March 2019

Are microRNAs located in genomic regions associated with cancer?

artículo científico publicado en 2006

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

artículo científico publicado en 2017

Autophagy role(s) in response to oncogenes and DNA replication stress

artículo científico publicado en 2019

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder

artículo científico publicado en 2008

Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.

artículo científico publicado en 2012

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties

artículo científico publicado en 2014

Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

artículo científico publicado en 2016

Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer

artículo científico publicado en 2008

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer

artículo científico publicado en 2009

Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer.

artículo científico publicado en 2017

Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics ⬇️

artículo científico publicado el 1 de septiembre de 2003

Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project

scientific article published on 28 November 2012

Comparative analysis of discrete exosome fractions obtained by differential centrifugation

artículo científico publicado en 2014

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers

article

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

artículo científico publicado en 2016

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

artículo científico publicado en 2017

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development

artículo científico publicado en 2009

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

artículo científico publicado en 2011

DNA Microarrays and Genetic Testing

Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification

artículo científico publicado en 2007

Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation

artículo científico publicado en 2012

Diagnostic and prognostic microRNAs in stage II colon cancer.

artículo científico publicado en 2008

Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms

artículo científico publicado en 2008

Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases

artículo científico publicado en 2018

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis

artículo científico publicado en 2011

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

artículo científico publicado en 2019

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

artículo científico publicado en 2007

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs

artículo científico publicado en 2011

Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature

artículo científico publicado en 2017

Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes

article

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

artículo científico publicado en 2012

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

artículo científico publicado en 2012

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy

artículo científico publicado en 2015

External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort

artículo científico publicado en 2014

FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.

artículo científico publicado en 2016

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

artículo científico publicado en 2018

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

article

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification

artículo científico publicado en 2004

Gene expression profiling of noninvasive primary urothelial tumours using microarrays

artículo científico publicado en 2005

Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death

artículo científico publicado en 2012

Gene signatures for risk-adapted treatment of bladder cancer

artículo científico publicado en 2008

Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset

artículo científico publicado en 2017

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

artículo científico publicado en 2009

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

artículo científico publicado en 2016

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

scientific article published on 31 March 2020

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

artículo científico publicado en 2009

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

artículo científico publicado en 2014

High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy

artículo científico publicado en 2011

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

artículo científico publicado en 2009

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

artículo científico publicado en 2014

Identification of ADAM12 as a Novel Basigin Sheddase

artículo científico publicado en 2019

Identifying distinct classes of bladder carcinoma using microarrays

artículo científico publicado en 2002

Immunochemical Determination of Cellular Content of Translation Release Factor RF4 in Escherichia coli

scholarly article by Lars Dyrskjøt et al published 1 September 1999 in IUBMB Life

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells

artículo científico publicado en 2008

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer ⬇️

artículo científico publicado en 2011

Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube

artículo científico publicado en 2007

Large-scale genomic comparison of UTUC and bladder tumours

scientific article published on 01 March 2019

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

artículo científico publicado en 2017

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

artículo científico publicado en 2011

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

artículo científico publicado en 2011

Molecular Profiling of ADAM12 in Human Bladder Cancer

scientific article published on 01 December 2006

Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?

scientific article published on 17 September 2018

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

scientific article published on 25 September 2020

Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.

artículo científico publicado en 2018

Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.

artículo científico publicado en 2017

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer

artículo científico publicado en 2012

Mutational context and diverse clonal development in early and late bladder cancer.

artículo científico publicado en 2014

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer ⬇️

artículo científico publicado en 2014

Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue

artículo científico publicado en 2014

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling

artículo científico publicado en 2016

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

artículo científico publicado en 2006

Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients.

artículo científico publicado en 2018

Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma

artículo científico publicado en 2016

Pervasive chromosomal instability and karyotype order in tumour evolution

artículo científico publicado en 2020

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts

artículo científico publicado en 2010

Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer

artículo científico publicado en 2017

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study

artículo científico publicado en 2017

Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors

artículo científico publicado en 2014

Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420-33: A Statement from the International Bladder Cancer Network

scientific article published on 29 November 2019

Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers.

artículo científico publicado en 2007

Recent developments in molecular profiling of bladder cancer

artículo científico publicado en 2006

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5

artículo científico publicado en 2020

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

artículo científico publicado en 2020

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours.

artículo científico publicado en 2014

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors

artículo científico publicado en 2005

SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation

artículo científico publicado en 2008

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization

artículo científico

STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer

artículo científico publicado en 2018

Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.

artículo científico publicado en 2012

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

artículo científico publicado en 2010

Snail1 is over-expressed in prostate cancer

artículo científico publicado en 2009

Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma

artículo científico publicado en 2016

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight

artículo científico publicado en 2021

Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity

artículo científico publicado en 2021

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

artículo científico publicado en 2013

The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis

scientific article published on 12 July 2013

The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer

artículo científico publicado en 2016

The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer

artículo científico

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

artículo científico publicado en 2011

The use of molecular analyses in voided urine for the assessment of patients with hematuria.

artículo científico publicado en 2013

Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.

artículo científico publicado en 2017

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells

artículo científico publicado en 2012

Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis

artículo científico publicado en 2011

Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness

artículo científico publicado en 2015

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

artículo científico publicado en 2016

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

artículo científico publicado en 2009

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

artículo científico publicado en 2012

Lista de obras de Lars Dyrskjøt

A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine

A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical Outcome

A dual program for translation regulation in cellular proliferation and differentiation

A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.

APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer

Abstract 3657: MCM7, ADAM10, TRIM29, Aurora Kinase B, and Cyclin D1: A panel of prognostic protein markers for progression in non-muscle invasive bladder cancer - a multicenter tissue microarray validation study

Adaptive differences in gene expression in European flounder (Platichthys flesus)

Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis

Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR.

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

Are microRNAs located in genomic regions associated with cancer?

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

Autophagy role(s) in response to oncogenes and DNA replication stress

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder

Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties

Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer

Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer.

Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics ⬇️

Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project

Comparative analysis of discrete exosome fractions obtained by differential centrifugation

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

DNA Microarrays and Genetic Testing

Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification

Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation

Diagnostic and prognostic microRNAs in stage II colon cancer.

Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms

Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs

Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature

Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy

External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort

FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification

Gene expression profiling of noninvasive primary urothelial tumours using microarrays

Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death

Gene signatures for risk-adapted treatment of bladder cancer

Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer

High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

Identification of ADAM12 as a Novel Basigin Sheddase

Identifying distinct classes of bladder carcinoma using microarrays

Immunochemical Determination of Cellular Content of Translation Release Factor RF4 in Escherichia coli

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer ⬇️

Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube

Large-scale genomic comparison of UTUC and bladder tumours

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

Molecular Profiling of ADAM12 in Human Bladder Cancer

Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

Molecular markers increase precision of the European Association of Urology non-muscle invasive bladder cancer progression risk groups.